Base de crème barrière aux céramides

1. INCI et CAS

INCI: Ceramide NP · CAS: 100403-19-8

2. Rôle dans la formule

Ceramide NP is listed as a ceramide lipid in this development reference. The recorded formula also lists Butyrospermum Parkii Butter and Cholesterol. Review the lipid combination in the complete formula; ingredient presence alone does not establish barrier performance.

3. Niveaux d'emploi typiques (repère de formulation)

• The formulation record gives 0.35% w/w as the component allocation.

Introduce from a pre-dispersed lipid concentrate or a warm oil phase. Avoid long holds at high heat after the lipids melt.

4. Sources réglementaires et conformité mondiale

• This record describes a development reference; it does not qualify the supplier material or completed product for approval; This entry does not approve a completed product.

5. Sécurité et évaluation des risques

Read the recorded level as a cosmetic formulation guide; no drug approval or OTC-monograph status follows from this guide and the completed formula still requires stability and patch testing.

6. Stabilité et conditionnement

For bulk storage, avoid warmth and direct sun and keep the container closed; if oxidation risk calls for it, review a pump or airless format; assess the confirmed formula for stability and package compatibility.

7. Formulations d'allégations (à faire / à éviter)

• This guide frames Ceramide NP's cosmetic direction around ceramide barrier-lipid.

• This formulation entry does not establish drug claims, cure claims, or a certification that is absent from the product records.
• This reference for Ceramide NP does not substantiate skin whitening, acne care, sweat reduction, sun protection, or hair-growth outcomes.

1. INCI et CAS

INCI: Cholesterol · CAS: 57-88-5

2. Rôle dans la formule

Cholesterol is listed as a lipid component in this development reference. The recorded formula also lists Butyrospermum Parkii Butter and Ceramide NP. Review its place in the recorded lipid combination and evaluate the complete formula.

3. Niveaux d'emploi typiques (repère de formulation)

• The component's reference allocation is recorded at 0.3% w/w.

Melt with the ceramide phase and cool under controlled shear.

4. Sources réglementaires et conformité mondiale

• This record describes a development reference; it does not certify the supplied material or completed cosmetic; This entry does not approve a completed product.

5. Sécurité et évaluation des risques

This level is a cosmetic-formulation guide; the note establishes neither drug approval nor OTC-monograph status so assess patch response and stability in the final formula.

6. Stabilité et conditionnement

Keep bulk supplies closed, cool, and protected from sunlight; select packaging with the formula's oxidation sensitivity in mind; follow with stability and packaging checks on the confirmed batch.

7. Formulations d'allégations (à faire / à éviter)

• The formulation note describes Cholesterol as part of a cosmetic direction focused on lamellar co-lipid.

• This ingredient reference cannot substantiate drug effects, cures, or certification claims that go beyond the documented ingredient information.
• The available details for Cholesterol does not confirm whitening, acne care as treatment, perspiration reduction, sun protection, or hair growth.

1. INCI et CAS

INCI: Butyrospermum Parkii Butter · CAS: 91080-23-8

2. Rôle dans la formule

Butyrospermum Parkii Butter is listed as a butter in this development reference. The recorded formula also lists Ceramide NP and Cholesterol. Review the contribution to body and application feel in the complete formula.

3. Niveaux d'emploi typiques (repère de formulation)

• The listed guide allocation for this component is 8% w/w.

For Butyrospermum Parkii Butter, use an oil-phase melt and shear during cool-down to limit grain formation.

4. Sources réglementaires et conformité mondiale

• This record describes a development reference; it establishes no approval for the raw material or the final product; The completed formula is not approved by this reference.

5. Sécurité et évaluation des risques

This formulation note gives a cosmetic-use reference level; no drug approval or OTC-monograph status follows from this guide and the completed cosmetic needs its own patch and stability checks.

6. Stabilité et conditionnement

Hold the bulk material in a sealed, cool place shielded from light; evaluate packaging against the formula's susceptibility to oxidation; then verify formula stability and pack compatibility on the confirmed batch.

7. Formulations d'allégations (à faire / à éviter)

• The recorded cosmetic positioning for Butyrospermum Parkii Butter highlights shea cushion.

• The available ingredient details provides no basis for drug-treatment outcomes, clinical cures, or certifications not documented for the SKU.
• The ingredient record for Butyrospermum Parkii Butter does not substantiate skin whitening, treatment of acne, sweat control, UV protection, or hair-growth results.